IconFRA:IJF +1.46%87 OCF Margin % is 8.21% as of Mar. 2026, which is 45% below its 10-year median of 14.92. GuruFocus rates FRA:IJF with a GF Score™ of 87/100 and a GF Value™ of €186.62 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Icon ranks better than 61.76% on this metric.
OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Icon's Cash Flow from Operations for the
three
months ended in Mar. 2026 was €144 Mil. Icon's Revenue for the
three
months ended in Mar. 2026 was €1,759 Mil. Therefore, Icon's OCF Margin % for the quarter that ended in Mar. 2026 was 8.21%.
The historical rank and industry rank for Icon's OCF Margin % or its related term are showing as below:
FRA:IJF'
s OCF Margin % Range Over the Past 10 Years
Min: 7.28 Med: 14.92 Max: 21.79
Current: 11.32
During the past 13 years, the highest OCF Margin % of Icon was 21.79%. The lowest was 7.28%. And the median was 14.92%.
FRA:IJF's OCF Margin % is ranked better than 61.76% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: 4.755
vs FRA:IJF: 11.32
Icon OCF Margin % Related Terms
Icon OCF Margin % Historical Data
* Premium members only.
The historical data trend for Icon's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:IJF vs RVTY, CRL, MEDP: OCF Margin % Comparison
For the Diagnostics & Research subindustry, Icon's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Icon OCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Icon's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Icon's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Icon (FRA:IJF) has a OCF Margin % of 8.21% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Icon and its competitors. This is 45% below median its historical median of 14.92. Over the past decade, Icon's OCF Margin % has ranged from 7.28 to 21.79. According to the industry distribution chart, Icon ranks #78 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 38.2%.
Is Icon's OCF Margin % too high?
Icon's current OCF Margin % of 8.21% is 45% below median its 10-year median of 14.92. Over the past 10 years, this metric has ranged from a low of 7.28 to a high of 21.79. The Medical Diagnostics & Research industry median OCF Margin % is 4.76. Icon's value of 8.21% is 72.7% above this industry median. Based on the distribution chart, Icon ranks #78 out of 204 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Icon has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Icon's OCF Margin % compare to RVTY and CRL?
According to the Medical Diagnostics & Research industry distribution chart, Icon ranks #78 out of 204 companies for OCF Margin %. This puts Icon in the upper half of its industry. The industry median OCF Margin % is 4.76. Icon's value of 8.21% is 72.7% above this benchmark. Historically, Icon's own OCF Margin % has ranged from 7.28 to 21.79 over the past decade. While the company's 10-year median is 14.92 vs. the industry median of 4.76, Icon has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 4.76, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Icon's current OCF Margin % of 8.21% is 72.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Icon and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Icon's current OCF Margin % is 8.21%, which is 45% below median its own 10-year median of 14.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Icon stock overvalued right now?
Based on GuruFocus' analysis, Icon (FRA:IJF) is currently considered Modestly Undervalued. The stock's GF Value™ is €186.62, compared to a current price of €139.25 — trading 25.4% below its estimated fair value. The current OCF Margin % is 8.21%, which is 45% below median its 10-year median of 14.92 and 72.7% above the Medical Diagnostics & Research industry median of 4.76. Icon's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Icon (FRA:IJF), the current OCF Margin % is 8.21% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Icon (FRA:IJF) Overvalued in 2026?
Based on GuruFocus' analysis, Icon stock appears to be undervalued.
The current stock price of €139.25 is trading 25.4% below its estimated GF Value™ of €186.62.
GuruFocus considers Icon to be Modestly Undervalued.
Key valuation signals for FRA:IJF:
OCF Margin %: 8.21% (45% below median its 10-year median of 14.92)
GF Value™: €186.62 vs. price of €139.25 (25.4% below fair value)
Industry Position: 72.7% above the Medical Diagnostics & Research median (#78 of 204)
No single metric tells the full story. See the FRA:IJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
87GF Score
Get the complete analysis for FRA:IJF
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:IJF has been successfully added to your 
